rfhg_56230.1

Basic information about the TSS

---

TSS ID: rfhg_56230.1 Species: human Chr: chr4		Start: 15681723 End: 15681729 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3552833,EH38E2283256)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000515697.5:4 GeneID: 285550 HGNC/MGI_ID: HGNC:27740 UniProt_ID: Nearer transcript ids and distances:

Gene_name: FAM200B Gene_symbol: FAM200B Gene_synonyms: C4orf53 Gene_source: HGNC:27740

TATA-Box annotation

---

Distance to TSS:	-101
Nearest PromoterID:	NM_001145191
Entrez ID:	285550
Nearest Unigene:	Hs.399980
Nearest Refseq:	NM_001145191
Nearest Ensembl:	ENSG00000237765
Gene Name:	FAM200B
Gene Alias:	C4orf53
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.571429
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@FAM200B p2@FAM200B p3@FAM200B p4@FAM200B p5@FAM200B p6@FAM200B
Sample		p1@FAM200B	p2@FAM200B	p3@FAM200B	p4@FAM200B	p5@FAM200B	p6@FAM200B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.99	2.73	0.78	0.97	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.26	5.06	1.82	1.01	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	18.52	2.12	1.16	0.58	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	25.57	1.87	0.42	0.42	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	23.85	2.25	1.80	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	23.06	2.33	0.97	0.58	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	24.40	3.92	1.09	1.31	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	19.38	2.91	0.48	0.73	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	29.07	4.27	0.64	0.64	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	35.94	1.74	0.00	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	27.49	1.62	0.00	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.05	1.63	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	92.20	15.96	9.35	0.81	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	80.74	13.38	7.82	0.90	0.00	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	86.50	13.61	8.78	1.54	0.88	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	73.44	11.32	5.03	2.26	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	66.40	11.58	5.24	0.44	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	72.13	9.70	8.44	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	75.17	3.73	4.80	1.60	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	92.52	18.96	9.18	1.05	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	86.07	16.17	6.42	0.80	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	87.87	15.36	6.56	1.21	0.52	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	65.92	9.31	5.30	0.90	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	75.47	10.92	3.88	1.21	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	82.04	12.90	5.68	1.29	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	88.31	13.61	9.81	1.58	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	96.70	10.99	4.95	2.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	88.41	15.32	6.13	1.89	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	81.41	12.92	8.40	1.62	0.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	80.89	15.38	7.78	0.90	0.00	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	95.04	12.56	4.61	0.84	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	98.86	11.33	7.23	1.56	0.59	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	86.31	13.29	8.86	1.48	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	90.22	14.18	9.24	1.48	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	85.64	16.08	6.54	0.93	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	82.59	15.14	5.37	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	97.69	18.39	8.18	0.82	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	81.20	12.69	4.84	1.01	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	113.44	16.75	7.29	1.35	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	101.55	18.00	5.52	2.16	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	90.10	16.70	5.41	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	102.62	16.98	9.22	1.46	0.73	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	96.59	16.45	6.33	1.05	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	95.98	17.48	8.04	1.40	0.70	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	115.44	20.28	7.83	0.80	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	103.53	15.82	8.61	1.16	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	88.77	14.39	7.92	1.44	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	109.38	19.67	9.84	1.19	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	80.43	13.17	5.03	1.68	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	94.83	12.33	6.67	1.42	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	109.86	11.07	3.89	0.61	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	113.41	15.12	4.89	1.11	0.67	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	27.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	79.13	12.77	3.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	78.87	7.95	2.65	0.00	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	59.56	12.58	15.94	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	104.71	15.15	11.94	1.38	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	93.02	8.75	2.59	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	77.40	8.99	4.50	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	148.36	15.40	10.37	1.57	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	85.31	10.58	1.41	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	82.44	8.41	2.24	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	136.94	23.88	8.76	1.59	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	157.99	11.21	6.46	1.02	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	104.95	6.50	2.92	0.97	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	93.71	9.58	2.13	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	16.16	32.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	221.13	55.28	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	122.85	11.70	1.46	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	144.79	7.44	2.48	0.99	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	122.44	8.91	1.88	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	202.36	18.88	3.97	1.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	120.02	8.35	2.47	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	129.33	7.95	1.22	0.92	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	39.44	7.76	2.38	0.79	0.79	0.16
Adipocyte - breast, donor2	11327-117E4	28.88	7.70	2.73	1.44	0.80	0.16
Adipocyte - omental, donor1	11473-119C6	56.11	11.07	3.44	1.53	1.27	0.13
Adipocyte - omental, donor2	11474-119C7	30.65	10.46	3.74	2.99	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	44.88	10.72	1.00	1.34	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	57.42	10.85	1.91	1.28	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	4.40	2.20	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.42	2.71	2.26	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	11.47	6.43	6.08	1.04	0.87	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	26.21	9.19	2.93	0.59	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	28.31	3.35	0.77	0.26	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	23.97	4.18	2.23	0.28	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	25.28	4.70	2.35	0.00	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	37.80	13.67	5.07	0.88	1.29	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	29.37	3.55	2.90	0.00	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	23.99	4.80	5.33	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	28.38	7.79	5.56	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	38.26	11.23	5.41	0.83	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	31.14	6.78	2.51	0.75	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	25.53	9.82	1.96	0.33	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	22.53	8.22	3.96	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	30.28	9.50	1.33	0.44	0.66	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	11.12	1.43	0.36	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	3.59	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	28.60	4.86	0.90	0.18	0.54	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	8.37	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	22.80	3.08	1.03	0.21	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	25.52	8.24	5.03	0.57	0.92	0.11
Anulus Pulposus Cell, donor2	11463-119B5	19.59	6.86	4.41	0.49	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	43.58	9.88	2.70	1.35	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	42.11	7.81	3.04	0.87	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	55.65	6.42	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	40.65	9.27	2.99	1.49	0.90	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	46.79	16.44	2.53	2.53	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	53.47	7.26	3.96	0.00	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	41.91	9.42	1.95	1.30	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	50.49	11.17	1.94	1.46	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	58.79	6.53	0.59	0.59	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	37.66	14.31	2.64	0.38	0.38	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	44.27	15.96	1.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	65.20	7.52	2.51	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	71.00	12.36	1.15	0.16	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	53.23	12.28	0.00	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	90.17	11.16	2.26	0.30	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	44.47	7.50	1.61	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	52.15	13.98	2.83	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	60.41	6.15	2.41	1.07	1.07	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	49.75	3.90	2.93	0.00	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	56.06	10.95	3.81	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	48.03	6.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	14.16	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	55.40	13.89	2.57	0.86	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	39.80	16.02	6.31	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	68.30	11.76	4.93	1.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	52.09	4.85	1.21	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	43.89	8.55	4.56	0.00	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	56.22	12.40	3.63	1.28	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	51.36	3.10	2.06	0.77	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	53.49	8.91	0.94	0.00	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	46.62	10.61	2.89	1.29	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	46.37	7.13	0.00	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	38.61	9.36	1.75	0.58	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	51.48	10.84	3.01	0.90	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	58.21	8.32	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	48.31	9.66	4.07	0.51	2.03	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	63.93	12.23	2.04	0.25	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	44.48	8.26	1.91	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	42.72	8.63	2.16	1.29	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	59.48	12.91	1.91	0.85	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	57.71	7.54	1.45	0.00	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	53.85	11.34	3.78	0.94	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	55.10	9.83	3.22	0.34	0.68	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	67.17	9.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	59.15	8.45	0.00	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	58.11	12.01	2.36	0.86	0.86	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	63.17	6.02	1.20	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	33.53	13.85	2.19	3.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	59.08	11.72	2.30	1.38	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	53.56	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	98.64	11.19	4.32	1.27	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	54.91	11.56	3.51	0.62	0.62	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	48.04	7.34	1.53	0.92	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	38.72	11.95	4.30	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	56.77	6.65	1.77	0.89	0.67	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	47.30	4.58	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	37.11	13.29	2.22	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	55.08	9.80	3.44	0.79	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	51.61	5.82	1.09	0.73	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	74.80	14.25	5.65	2.82	0.98	0.49
Astrocyte - cerebellum, donor2	11580-120F5	44.16	10.44	2.40	0.68	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	28.32	3.99	3.57	0.42	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	91.68	27.54	14.99	1.05	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	76.84	19.09	6.47	1.13	1.62	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	79.95	22.37	6.12	2.09	0.75	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	4.01	2.18	3.44	19.38	4.70	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	7.14	2.26	3.38	15.28	3.01	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	5.69	2.73	4.21	14.57	2.50	1.71
Basophils, donor1	12241-129G9	27.72	2.88	4.97	12.03	3.14	0.78
Basophils, donor2	12242-129H1	25.98	1.44	7.22	17.68	2.89	0.72
Basophils, donor3	12243-129H2	33.96	4.26	9.55	7.50	1.76	1.47
Bronchial Epithelial Cell, donor1	11511-119G8	23.07	3.67	1.29	0.22	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	11.89	1.37	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	14.44	3.14	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	8.11	2.50	0.42	0.21	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	9.90	4.84	0.92	0.00	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	19.43	5.58	3.78	0.00	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4.02	1.34	9.89	24.53	6.29	1.65
Burkitt's lymphoma cell line:RAJI	10476-106I8	3.49	2.10	5.59	17.23	3.73	2.79
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	11.19	2.56	20.15	7.99	5.76	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	62.05	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	56.92	4.51	12.40	7.89	2.82	0.56
CD14+ Monocytes, donor2	11305-117B9	41.39	3.71	5.75	9.28	1.11	1.67
CD14+ Monocytes, donor3	11381-118B4	41.71	3.07	7.03	8.78	0.88	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	52.93	7.36	1.98	1.42	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	45.11	7.96	3.79	4.55	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	55.89	11.18	3.94	2.30	1.97	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	24.43	2.17	9.25	4.63	1.30	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	11.16	1.51	3.02	2.41	1.21	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	17.77	2.13	5.21	3.08	0.71	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.58	1.84	4.85	3.68	0.33	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	14.08	0.83	4.97	2.76	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	16.61	1.74	4.21	3.47	0.25	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	17.03	0.78	6.07	3.92	0.39	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	14.60	1.07	4.99	2.67	0.18	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	29.38	2.61	6.53	5.01	0.87	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	14.75	1.17	5.15	5.62	0.94	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	19.54	1.06	7.92	4.75	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	31.06	2.22	4.44	5.55	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	15.92	1.78	5.21	3.72	0.30	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.38	1.20	6.19	2.39	0.20	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	20.61	1.67	5.83	3.54	0.83	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	16.01	0.92	6.63	3.20	0.46	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	14.48	0.68	7.01	2.26	0.90	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	12.22	0.87	2.62	0.87	0.44	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	16.68	2.15	3.50	7.53	1.08	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	16.22	1.74	5.93	2.97	0.52	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	26.93	1.68	5.05	2.52	0.00	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.39	2.02	6.98	3.12	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.28	0.00	3.52	1.41	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.58	1.75	2.19	0.88	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	17.09	2.79	4.88	3.84	1.39	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	18.21	1.49	5.95	1.86	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	39.45	3.88	7.54	5.60	0.43	2.16
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	12.28	0.41	5.32	3.69	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	11.13	1.62	3.48	1.85	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	18.10	1.39	6.03	1.62	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	18.96	2.62	8.28	9.59	4.58	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	15.71	2.54	8.55	10.63	3.23	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	35.74	4.33	7.80	7.80	4.33	2.82
CD14+CD16- Monocytes, donor1	11788-124B6	110.10	9.97	11.37	18.53	5.76	2.49
CD14+CD16- Monocytes, donor2	11799-124C8	94.83	9.61	10.48	10.83	2.10	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	130.66	10.48	16.28	14.49	4.46	2.45
CD14-CD16+ Monocytes, donor1	11790-124B8	14.54	2.55	9.95	10.97	5.87	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	8.34	1.54	5.93	8.34	3.07	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	13.69	3.16	8.21	9.05	3.37	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	2.03	40.65	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	2.71	0.00	7.46	33.22	2.03	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	3.11	1.04	3.11	30.03	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	10.66	1.07	4.26	21.32	2.13	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	4.29	0.00	3.75	36.99	4.82	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.70	0.00	3.51	35.10	5.62	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.14	0.78	5.49	32.94	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	1.32	6.59	36.91	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	1.64	0.00	2.47	11.51	0.00	2.47
CD19+ B Cells, donor2	11624-122B4	0.73	0.00	5.08	18.14	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	3.53	0.50	1.51	8.08	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	4.04	1.62	14.55	18.99	11.31	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.80	5.19	9.19	11.98	5.59	2.00
CD34+ Progenitors, donor1	11545-120B6	1.00	1.00	8.03	11.04	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	8.99	0.56	12.92	6.74	2.81	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	10.15	2.25	14.28	13.15	3.38	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	18.04	1.35	14.21	17.81	6.54	1.58
CD4+ T Cells, donor1	11225-116C1	1.43	0.36	9.64	42.85	4.28	1.79
CD4+ T Cells, donor2	11306-117C1	1.84	0.00	9.80	37.97	1.22	1.22
CD4+ T Cells, donor3	11382-118B5	2.74	0.61	5.49	31.41	2.74	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1.53	2.04	4.59	29.35	6.38	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	1.12	0.22	5.61	27.85	4.94	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1.15	1.15	4.89	35.36	8.62	2.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	3.79	0.00	10.43	85.81	3.79	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	4.21	0.70	18.26	99.73	12.64	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	3.30	36.26	9.89	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	3.47	0.29	2.75	26.88	4.19	1.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.85	0.34	2.54	18.13	4.58	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	1.13	0.32	2.58	16.60	2.90	1.93
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.90	0.45	9.41	52.90	3.59	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1.75	2.80	9.08	68.48	6.64	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1.76	0.00	7.04	49.28	4.84	5.28
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	2.95	0.42	6.32	37.53	5.90	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	1.25	0.21	4.16	24.52	3.53	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	2.34	0.67	2.34	15.70	4.68	3.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1.90	0.82	14.68	82.40	5.17	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3.22	1.07	9.65	106.12	8.04	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	0.00	3.59	68.14	10.76	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.74	0.74	4.08	25.77	7.97	1.85
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	3.03	0.00	4.98	27.94	5.42	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	2.31	0.63	4.83	25.22	4.62	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	4.55	0.51	8.60	51.57	8.09	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	2.60	0.87	14.30	53.72	7.80	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	2.61	0.44	10.90	51.86	8.72	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	3.96	0.99	7.92	64.83	6.43	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	3.69	0.92	10.16	51.70	9.23	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	6.98	0.00	11.17	78.17	8.37	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	12.18	1.66	11.08	71.72	8.86	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	7.61	0.98	13.99	84.91	13.74	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	12.32	1.54	1.54	72.38	3.08	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	10.03	1.07	8.95	64.10	8.95	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	5.54	0.00	16.62	62.32	6.92	2.77
CD8+ T Cells, donor1	11226-116C2	2.29	0.65	2.29	20.30	2.29	1.96
CD8+ T Cells, donor2	11307-117C2	1.88	0.00	3.75	21.40	0.75	1.50
CD8+ T Cells, donor3	11383-118B6	2.27	0.25	3.53	33.08	2.78	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.73	2.75	1.15	1.84	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	9.11	1.20	0.96	1.68	0.96	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	7.66	0.55	2.46	2.74	0.82	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	8.71	1.80	1.20	3.00	1.50	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.88	1.92	1.68	1.68	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8.41	1.14	1.14	2.73	1.59	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	11.08	1.96	1.09	3.26	1.09	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	10.79	1.58	0.26	1.84	0.79	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	12.66	1.41	0.23	1.88	1.88	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	11.47	1.81	1.51	3.92	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.04	1.45	0.58	2.91	2.32	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	9.06	3.20	1.07	2.40	0.80	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	8.32	1.31	0.44	0.44	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	11.84	3.64	1.37	2.73	1.82	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	10.44	0.00	0.75	1.49	2.98	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.28	1.08	1.08	2.52	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.34	0.29	0.86	2.59	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.01	1.18	1.18	1.89	0.71	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	11.09	0.95	0.63	1.27	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	11.69	0.62	0.62	0.92	1.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	14.43	0.96	1.28	0.96	0.32	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.80	0.38	0.76	2.29	1.15	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.09	1.58	0.79	1.97	1.58	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	1.51	0.00	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	17.67	2.41	0.00	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.08	2.10	0.70	0.70	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	30.05	3.01	2.00	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	31.07	5.48	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	38.54	2.96	1.48	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	26.41	5.58	2.21	0.11	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	24.61	7.28	4.85	1.04	1.04	0.35
Chondrocyte - de diff, donor2	11338-117F6	24.52	5.33	1.78	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	25.60	7.85	3.98	0.46	0.46	0.23
Chondrocyte - re diff, donor2	11339-117F7	25.96	3.58	1.79	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	16.98	3.64	0.81	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	114.18	20.66	6.20	2.87	0.80	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	62.85	13.25	4.92	2.14	0.64	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	78.85	19.56	5.31	1.77	0.44	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	17.97	6.33	11.19	4.13	3.76	0.37
Corneal Epithelial Cells, donor1	11526-119I5	35.57	5.27	1.10	0.22	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	31.85	7.96	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	39.11	4.86	1.28	1.28	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	55.31	5.45	1.32	0.00	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	53.62	3.47	0.63	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	58.66	10.35	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	54.53	6.59	0.22	0.11	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	9.57	0.34	6.83	8.54	3.07	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	9.79	0.65	11.10	7.83	3.92	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	11.13	1.45	5.81	10.65	4.84	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	14.51	2.00	2.17	0.50	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	12.32	2.93	0.59	0.00	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	19.51	3.11	0.57	0.00	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	21.63	2.75	1.18	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	21.23	3.49	1.16	0.29	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	18.82	3.53	1.65	0.00	0.24	0.24
Endothelial Cells - Artery, donor3	11413-118E9	16.48	2.80	1.05	0.70	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	32.80	4.88	3.10	0.22	0.89	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	42.60	7.61	3.35	0.91	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	63.15	5.92	2.26	0.56	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	41.90	6.24	1.78	0.00	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	36.45	5.73	0.00	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	23.82	3.40	2.41	0.43	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	50.01	6.00	2.40	0.00	1.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	18.87	3.67	1.57	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	39.01	4.60	4.22	0.87	1.24	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	21.73	4.56	4.13	0.43	0.87	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	29.31	5.13	2.93	0.61	0.98	0.00
Endothelial Cells - Vein, donor1	11267-116G7	7.96	3.41	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	14.67	2.10	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	16.64	3.45	1.73	0.31	0.31	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	45.74	0.00	0.00
Eosinophils, donor2	12245-129H4	39.61	6.60	1.65	21.45	8.25	0.00
Eosinophils, donor3	12246-129H5	39.24	0.00	0.00	57.07	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	22.97	4.40	1.22	0.24	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	38.59	9.85	1.64	0.41	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	46.53	8.54	1.64	2.08	0.22	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	45.39	7.58	2.71	0.43	0.65	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	42.69	8.85	2.55	2.06	0.97	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	67.69	17.06	3.96	2.73	0.68	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	43.88	7.70	2.21	0.11	0.42	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	15.28	4.74	1.84	0.00	0.79	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	34.55	8.97	3.32	1.99	1.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	32.66	8.62	1.36	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	13.64	0.76	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	35.80	5.68	0.47	0.79	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	40.62	13.64	3.64	0.61	0.91	0.30
Fibroblast - Cardiac, donor5	11456-119A7	34.39	7.99	2.28	0.25	0.63	0.00
Fibroblast - Cardiac, donor6	11460-119B2	25.01	7.43	1.52	0.76	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	46.63	10.72	3.89	0.54	2.01	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.28	4.75	2.59	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	54.20	5.86	11.72	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	56.51	10.38	1.85	0.92	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	27.48	7.46	9.16	0.34	0.85	0.00
Fibroblast - Dermal, donor1	11269-116G9	18.55	8.45	3.05	0.00	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	13.68	2.36	3.30	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	12.81	3.51	2.30	0.24	0.24	0.00
Fibroblast - Dermal, donor4	11450-119A1	23.29	5.77	3.05	0.79	1.02	0.00
Fibroblast - Dermal, donor5	11454-119A5	21.98	5.93	3.14	0.52	1.40	0.00
Fibroblast - Dermal, donor6	11458-119A9	26.31	7.15	2.60	0.81	0.65	0.00
Fibroblast - Gingival, donor1	11237-116D4	24.15	6.04	5.41	0.42	1.46	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	42.71	5.76	5.24	0.26	1.05	0.00
Fibroblast - Gingival, donor2	11318-117D4	24.12	8.43	3.16	0.66	0.92	0.13
Fibroblast - Gingival, donor3	11394-118C8	19.53	8.32	5.51	0.10	1.16	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	5.19	3.12	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.80	4.05	1.76	0.18	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	43.34	8.73	2.81	0.94	0.94	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	39.76	5.41	2.43	1.08	0.81	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	13.06	0.00	0.00	0.00	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	58.94	7.46	3.95	1.46	0.73	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	46.09	7.09	3.41	0.82	0.41	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	36.64	6.36	2.08	0.55	0.99	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	30.67	6.90	5.87	0.29	0.59	0.00
Fibroblast - Lung, donor1	11270-116H1	8.16	5.44	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	16.41	8.95	2.98	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	14.14	3.17	1.90	0.21	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	79.14	10.83	0.83	0.83	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	19.58	8.39	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	33.31	3.08	0.28	0.84	0.84	0.00
Fibroblast - Mammary, donor1	11540-120B1	46.69	7.71	2.84	0.41	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	35.95	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	24.63	6.98	4.46	0.39	1.75	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	22.75	6.98	3.94	0.61	0.76	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	23.26	8.87	6.12	0.61	2.14	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	32.82	5.34	2.67	0.76	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	31.86	8.91	3.24	1.35	0.27	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	20.41	4.99	2.32	0.12	0.35	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	34.04	5.75	2.21	0.77	0.66	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	40.84	7.31	2.44	1.42	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	22.72	5.35	2.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.07	4.74	2.37	0.79	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	15.68	2.38	1.19	0.60	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	46.36	8.53	3.37	0.53	0.53	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	37.64	6.11	3.94	0.00	1.18	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	17.75	5.42	1.20	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	48.58	9.72	5.07	0.54	1.30	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	13.92	3.80	0.76	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	40.53	5.91	3.45	0.49	0.98	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	15.64	5.61	1.60	0.40	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	36.17	6.03	2.51	0.70	0.80	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	17.83	5.14	2.12	0.00	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	43.16	6.63	4.23	0.25	0.66	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	47.52	11.28	6.84	1.03	0.85	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	18.06	6.57	2.63	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	45.59	7.56	4.05	0.85	1.81	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	48.07	7.59	1.18	0.51	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	45.16	7.84	5.80	0.63	0.78	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	4.36	5.23	0.00	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	34.15	7.45	1.21	0.17	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	38.26	8.85	2.08	0.00	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	30.66	3.07	2.04	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	38.28	3.83	1.53	2.30	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	42.11	5.10	1.28	2.55	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	66.18	11.98	2.28	3.14	0.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	63.42	9.93	3.03	1.65	1.38	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	63.47	8.90	2.51	0.68	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	54.68	10.10	3.57	1.98	0.40	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	62.12	11.37	5.02	1.06	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	54.47	12.07	1.63	0.00	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	81.81	13.27	3.10	3.54	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	22.47	3.96	2.40	0.99	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	30.29	5.66	1.85	0.62	0.49	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	27.94	4.03	1.34	1.07	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	38.78	6.44	1.86	1.36	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	31.28	7.61	1.52	0.97	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	35.58	4.68	1.83	0.61	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	42.21	5.02	1.83	0.46	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	33.13	5.61	1.62	1.00	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	37.60	6.12	1.75	1.09	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	44.32	5.02	2.95	0.89	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	38.15	6.36	2.70	0.79	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	36.64	6.03	0.45	0.45	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	40.33	4.03	1.81	0.40	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	35.46	7.12	2.54	0.51	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	47.71	4.88	1.51	1.33	0.27	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	46.93	5.51	2.19	0.42	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	57.72	4.10	3.24	0.17	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	28.88	4.32	2.10	0.22	0.11	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.60	5.24	2.75	0.83	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.74	4.29	1.84	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	44.56	8.66	3.30	0.41	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	30.67	4.50	3.23	0.69	0.35	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	32.02	4.00	1.33	0.67	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	28.44	5.07	1.32	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	27.30	4.55	3.32	0.12	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	38.90	4.21	2.59	0.00	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	33.68	3.21	4.81	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	22.17	3.70	1.71	0.38	0.38	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.00	4.27	1.42	0.32	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	34.97	2.74	1.82	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	26.13	4.50	1.25	0.10	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	25.03	2.63	2.42	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	29.46	3.37	1.68	0.56	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	22.50	5.65	1.02	0.19	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	33.16	4.28	0.53	0.53	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	31.06	3.06	0.77	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	25.65	3.76	1.04	0.13	0.39	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	29.00	5.96	2.17	0.54	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	36.13	4.42	2.03	0.18	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.19	3.29	2.41	0.66	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	37.69	8.93	0.99	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.66	4.35	2.24	0.79	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	21.18	3.03	3.43	0.40	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	28.97	4.83	5.34	0.51	1.78	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	37.03	8.96	1.99	1.19	0.60	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	18.80	3.85	1.85	1.08	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	23.32	6.55	2.45	1.02	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	52.57	5.63	2.50	0.31	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	57.36	5.65	2.26	0.57	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	42.43	4.61	1.38	0.46	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	2.47	4.95	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	50.67	6.58	1.93	0.77	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	67.39	9.63	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	3.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	41.01	6.18	0.65	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	41.59	7.41	0.41	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	42.23	5.31	3.08	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	36.28	8.17	1.63	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	36.07	2.52	2.52	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	47.39	4.77	2.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	41.44	3.06	4.42	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	73.09	2.09	6.26	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	41.81	2.29	2.86	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	29.01	2.07	2.07	0.89	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	40.66	1.69	1.69	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	48.05	5.38	1.66	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	47.64	6.67	0.69	0.23	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	0.00	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	43.44	5.77	1.54	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	45.31	6.19	2.61	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	59.53	4.01	0.67	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	43.15	4.62	3.47	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	47.24	4.11	2.74	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	9.94	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	54.73	7.08	2.36	0.94	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	48.28	4.22	1.81	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	52.39	5.60	3.05	1.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	56.24	5.58	1.99	0.80	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	59.70	6.91	3.45	0.00	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	51.94	7.08	3.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	53.09	10.50	0.58	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	42.13	4.83	2.63	0.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	41.54	7.63	1.70	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	45.37	8.36	1.79	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	48.04	6.79	1.94	0.49	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	13.70	2.28	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.55	4.16	3.74	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	20.24	2.25	1.12	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	15.54	5.07	6.34	0.63	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	23.39	9.61	6.27	1.25	2.09	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	27.39	7.89	1.74	2.79	0.35	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	32.24	7.60	1.69	2.03	0.51	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	27.53	8.19	1.37	1.14	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	28.20	7.11	1.20	3.72	0.11	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	32.88	6.88	0.86	3.65	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	26.05	4.95	1.08	1.51	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	28.77	7.60	1.74	2.49	0.12	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	33.11	6.35	0.86	1.72	0.00	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	25.31	4.49	1.60	1.28	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	34.14	1.68	2.24	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	33.33	3.03	0.00	0.43	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	76.67	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	49.03	8.82	3.17	0.71	0.71	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	29.06	4.36	2.91	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	31.12	7.17	1.22	0.52	0.17	0.00
Hepatocyte, donor1	11523-119I2	30.27	2.42	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	48.48	5.39	2.15	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	20.86	5.52	1.84	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	13.71	1.31	1.96	19.58	1.96	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	28.31	3.67	1.40	0.70	0.35	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	42.40	8.37	4.39	0.82	0.55	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	2.56	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	3.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	10.59	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	7.56	0.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	3.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	3.26	1.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.46	1.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.88	2.41	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	6.61	1.89	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	0.91	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	4.30	1.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	7.01	0.00	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	0.00	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.71	0.00	0.00	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	9.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.79	1.23	0.31	0.00	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.17	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.10	0.00	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	0.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	3.48	3.48	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	1.07	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	2.77	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	7.36	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	3.03	3.03	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	8.46	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	18.52	1.96	0.73	0.82	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	18.74	1.76	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	31.62	7.67	2.27	0.19	0.19	0.09
Keratinocyte - oral, donor1	11251-116E9	42.80	6.47	5.56	0.45	0.57	0.11
Keratocytes, donor1	11527-119I6	40.23	6.19	1.38	1.38	1.03	0.00
Keratocytes, donor2	11607-120I5	19.92	5.86	1.17	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	16.40	4.15	1.98	0.20	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	54.95	4.40	13.19	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	44.23	8.63	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	95.96	25.37	10.38	1.61	0.92	0.12
Lens Epithelial Cells, donor3	11690-122I7	64.99	14.33	3.73	1.61	0.30	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	55.26	5.45	2.37	0.47	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	28.74	2.23	1.12	0.56	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	45.65	4.56	2.20	0.31	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	31.73	4.30	1.61	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	31.52	2.84	1.58	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.54	3.13	1.83	0.43	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	41.04	2.46	0.82	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	21.74	3.29	2.02	0.00	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	26.46	3.38	1.83	0.84	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	41.93	4.75	0.79	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	32.77	2.71	2.13	0.78	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	22.40	2.22	0.56	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	39.37	3.14	3.48	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	31.96	3.34	0.48	0.48	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.53	2.75	1.10	0.69	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	42.81	4.62	2.16	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	24.94	1.87	0.94	0.31	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	26.17	2.56	0.73	0.73	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	35.21	5.59	0.99	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	26.07	2.93	1.17	0.00	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	27.38	1.00	1.24	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	46.07	6.30	1.94	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	31.51	4.04	0.54	0.54	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	29.37	2.72	1.82	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	49.25	4.15	1.04	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	31.20	2.51	1.26	0.42	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	23.46	1.80	1.80	0.75	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	37.15	6.19	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	28.79	2.63	1.13	0.56	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	24.60	2.76	1.70	0.42	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	44.10	5.81	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	27.12	2.32	0.66	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	27.26	2.35	1.86	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	45.17	2.59	1.85	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	32.12	1.73	0.74	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	26.81	1.65	1.51	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	41.17	2.89	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	35.00	3.35	1.83	0.30	1.22	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	39.19	3.22	1.96	0.84	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	47.65	2.49	2.13	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	30.54	3.39	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	20.85	2.02	0.62	0.31	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	42.26	1.79	1.79	1.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	29.07	6.21	0.98	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	20.25	3.06	2.35	0.47	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	46.65	5.07	1.61	0.37	0.74	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	24.84	2.82	0.51	0.26	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	27.45	3.58	1.19	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	4.53	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.18	4.60	5.37	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	13.36	3.71	2.97	0.00	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	10.16	1.69	3.81	0.42	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	2.11	4.22	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	15.88	0.93	1.87	0.00	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	13.40	2.58	2.06	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	13.08	7.14	3.57	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.51	2.26	2.49	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	17.74	2.33	2.62	0.00	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	19.36	5.85	4.05	1.35	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	18.16	2.98	4.06	0.00	0.41	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.81	2.57	2.05	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.17	4.23	4.59	1.41	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	15.99	2.67	6.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.77	1.53	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	24.55	2.93	3.47	0.27	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	20.59	2.83	5.86	0.76	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	13.50	0.00	2.45	0.61	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	10.60	6.52	2.45	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	17.91	2.50	1.87	0.62	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.06	1.96	3.36	0.56	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	13.39	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.81	2.90	4.64	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.34	2.69	1.79	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	19.36	3.87	3.87	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	13.08	4.60	2.12	0.35	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.49	2.58	1.48	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	4.61	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.58	3.84	3.45	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	3.40	1.70	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	12.31	1.64	1.64	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.56	4.97	2.26	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.95	0.72	2.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	19.42	2.99	3.73	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	11.52	3.34	1.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	14.21	2.58	2.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	15.41	5.99	3.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	13.66	1.67	4.00	0.67	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.08	0.60	1.81	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	11.38	0.71	2.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	16.84	5.16	5.16	0.34	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	10.73	2.15	2.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.14	4.04	4.04	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.11	1.48	2.59	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	13.96	5.81	4.65	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	4.23	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	15.61	3.20	1.60	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.08	2.91	3.63	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	12.26	2.30	6.90	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	22.20	3.45	4.93	0.49	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.94	1.88	3.76	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	21.62	3.02	3.52	1.01	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	17.12	1.80	1.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	17.21	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.03	2.67	5.34	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	15.25	2.74	3.13	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	18.47	3.30	3.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	15.57	5.71	7.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	15.31	1.75	5.25	0.00	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.33	0.56	2.80	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	17.22	4.86	3.97	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	14.27	5.40	5.01	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.17	3.54	2.53	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	13.94	6.25	3.84	0.48	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.13	2.39	2.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.15	2.43	0.61	1.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	10.38	1.38	2.08	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	12.54	3.42	3.04	0.00	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	17.04	2.58	1.55	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	16.33	3.02	1.81	0.60	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.36	2.85	3.80	0.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	11.73	4.80	3.20	1.60	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.77	1.72	3.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	9.77	3.09	3.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.85	2.83	2.12	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	19.86	2.84	2.27	1.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	7.90	1.66	2.91	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	12.53	1.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	14.61	2.51	4.59	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	12.55	3.25	3.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.04	0.67	1.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.23	2.67	3.21	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.34	2.42	1.62	0.81	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	0.92	1.84	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	13.34	0.89	1.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	14.25	5.13	3.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	8.44	1.53	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	11.49	2.19	3.83	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	1.34	4.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	9.88	1.04	2.86	0.26	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.91	1.99	1.33	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	4.16	4.16	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	36.92	6.38	1.14	0.68	1.60	0.23
Macrophage - monocyte derived, donor2	11313-117C8	57.99	8.07	0.55	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	55.19	8.13	1.18	0.13	0.52	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	49.92	11.68	1.06	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	69.56	7.76	1.74	0.48	0.48	0.00
Mallassez-derived cells, donor3	11930-125I4	57.96	7.09	2.08	0.69	0.97	0.14
Mammary Epithelial Cell, donor1	11273-116H4	30.59	4.68	2.99	1.20	0.50	0.00
Mammary Epithelial Cell, donor2	11350-117G9	44.30	4.63	1.16	1.45	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	13.47	2.49	0.25	0.75	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	12.88	2.03	12.88	20.34	16.27	5.42
Mast cell, donor1	11563-120D6	2.05	0.76	6.49	12.65	5.95	2.27
Mast cell, donor2	11565-120D8	2.38	0.89	5.65	5.35	5.65	0.89
Mast cell, donor3	11566-120D9	1.13	1.58	4.28	9.46	4.28	0.90
Mast cell, donor4	11567-120E1	0.71	0.18	5.32	5.50	3.37	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	3.99	0.89	5.21	15.86	9.98	3.22
Mast cell, expanded and stimulated, donor8	11942-126A7	3.50	0.58	2.33	2.92	4.09	1.75
Mast cell, expanded, donor5	11939-126A4	1.03	1.15	4.47	10.90	9.75	2.41
Mast cell, expanded, donor8	11941-126A6	1.67	0.50	4.02	6.69	4.85	2.01
Melanocyte - dark, donor1	11502-119F8	99.70	13.63	3.38	1.09	0.99	0.10
Melanocyte - dark, donor2	11582-120F7	30.46	4.85	2.08	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	36.58	9.06	2.83	0.43	0.58	0.07
Melanocyte - light, donor1	11274-116H5	13.40	2.82	0.47	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	11.60	4.09	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.07	1.73	0.87	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	25.20	5.52	1.25	0.00	0.62	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	28.24	5.11	1.34	0.54	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	58.66	8.04	2.68	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	52.11	7.20	2.11	1.36	0.99	0.12
Meningeal Cells, donor2	11573-120E7	38.29	11.44	1.76	0.44	1.32	0.00
Meningeal Cells, donor3	11654-122E7	46.21	5.62	3.50	1.39	0.98	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	32.22	9.12	7.13	2.57	2.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	46.79	6.24	2.72	0.81	0.70	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	1.31	1.31	0.00	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	26.16	5.23	3.92	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	28.70	6.46	0.72	0.72	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	36.00	7.20	3.60	0.21	0.42	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	27.65	9.05	3.02	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	30.55	5.93	2.20	0.88	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	23.38	3.65	1.46	2.92	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	22.71	4.71	3.89	1.23	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	31.58	7.06	7.34	0.69	1.52	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	28.62	1.86	1.86	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	39.60	4.21	3.42	0.79	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	20.48	3.56	3.26	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	43.55	3.84	0.64	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	21.62	4.25	4.61	0.71	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	28.15	5.32	5.00	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	32.66	6.53	0.73	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	58.34	12.73	3.18	1.59	1.33	0.00
Mesothelial Cells, donor2	12156-128G5	76.07	16.52	3.00	2.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	54.85	9.11	1.66	0.72	0.14	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	31.06	4.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	42.61	7.14	1.48	0.49	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	41.52	3.83	0.88	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	33.47	2.79	3.10	0.00	1.24	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	33.81	4.56	0.62	0.21	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	38.79	3.75	1.50	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	34.91	0.93	0.93	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	37.80	3.45	1.22	0.61	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	29.30	3.17	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	30.97	2.65	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	44.83	6.08	0.76	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	2.63	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	33.32	4.03	2.12	0.64	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	24.86	0.00	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	21.76	3.28	0.89	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	33.12	3.26	1.76	0.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	23.05	2.61	0.71	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	5.53	0.55	1.11	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	28.32	3.68	1.84	0.23	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.98	4.84	0.84	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	18.96	1.63	0.41	0.00	0.61	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	34.11	4.51	1.50	0.43	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.23	3.56	0.67	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	22.34	2.63	1.31	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	16.22	0.00	0.00	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	16.85	2.17	0.54	0.00	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	18.23	2.94	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	17.78	3.36	0.96	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	17.21	4.80	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	1.37	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	19.02	2.50	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	17.08	1.31	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	0.64	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	18.10	2.23	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.83	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	21.54	2.74	0.34	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.69	3.06	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.91	0.71	0.00	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.67	2.81	0.28	0.00	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.07	0.83	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	0.58	1.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	16.59	2.71	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.53	2.92	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	17.64	1.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.43	2.63	0.69	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	20.21	1.81	0.00	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	26.17	3.43	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	9.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.21	2.94	0.27	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	49.99	9.28	0.90	0.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.27	2.68	0.00	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	20.70	3.19	0.96	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.77	5.09	0.66	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.48	2.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	27.84	2.84	0.28	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	38.10	6.15	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	15.64	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	29.70	4.70	0.29	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	56.22	10.38	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	70.48	8.66	0.82	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	35.44	6.55	0.89	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	75.34	7.53	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	35.65	7.13	7.13	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	40.74	3.61	2.63	0.66	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	47.34	2.10	2.10	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	46.46	2.97	2.97	0.20	0.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	57.74	8.38	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	39.43	4.88	2.25	1.50	1.88	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	42.35	4.53	2.66	0.53	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	37.55	4.30	1.92	0.57	0.57	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	20.63	0.74	2.21	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	39.57	1.83	1.10	1.10	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	46.67	3.11	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	71.61	6.95	1.60	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	0.00	3.86	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	19.19	2.02	0.00	0.00	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	58.19	5.90	3.79	0.00	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	119.85	10.90	1.36	1.36	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	67.39	5.09	5.09	0.64	1.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	97.99	1.62	6.48	2.43	0.81	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	135.94	12.08	6.04	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	110.92	9.79	3.26	13.05	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	62.48	11.63	2.80	1.08	0.86	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	59.06	12.54	4.70	0.52	1.57	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	30.70	2.67	2.67	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	30.47	3.34	1.25	0.00	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	68.07	14.45	8.37	2.09	1.52	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	62.24	17.55	7.98	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	17.00	0.68	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	7.35	14.70	0.00	9.19	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	38.51	3.77	0.42	1.26	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	41.37	6.74	3.25	1.86	0.93	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	35.67	1.62	2.16	0.54	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	38.89	5.89	2.94	0.42	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	33.26	2.48	1.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	78.22	11.37	6.23	1.89	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	41.26	4.76	2.04	1.13	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	31.35	2.61	1.80	0.00	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	40.46	4.56	3.10	0.00	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	47.74	5.83	2.12	0.53	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	31.22	3.60	0.60	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	71.21	8.20	12.80	0.33	1.31	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	35.29	5.37	1.63	0.81	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	37.92	7.58	3.35	0.00	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	29.54	2.11	1.41	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	41.83	4.14	4.60	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	42.74	3.86	1.61	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	82.43	13.45	12.76	0.69	2.41	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	42.98	15.17	10.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	24.95	4.01	2.23	0.22	0.67	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	36.41	2.54	2.54	0.85	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	41.54	6.17	5.46	0.71	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	37.77	2.58	1.29	0.43	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	27.08	18.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	31.99	5.00	1.00	1.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	30.66	2.71	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	30.95	3.17	0.79	0.79	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	30.65	2.79	5.57	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	62.43	7.57	4.16	0.38	1.51	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	37.15	5.54	0.65	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.05	0.87	1.31	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	36.18	5.43	1.81	0.45	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	38.80	1.76	0.00	0.88	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	31.91	1.33	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	41.17	1.98	0.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	32.16	3.83	1.53	0.38	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.38	3.33	5.14	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	36.91	4.64	2.65	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	28.46	2.71	1.36	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	5.11	20.44	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	46.95	4.88	1.83	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	35.88	5.67	1.89	0.63	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	18.76	2.12	2.42	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	32.44	3.96	0.79	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	65.75	7.94	9.07	2.27	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	5.06	20.23	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	34.04	10.31	4.10	1.37	1.24	0.25
Myoblast, donor2	11322-117D8	23.59	8.25	4.03	0.19	0.19	0.00
Myoblast, donor3	11398-118D3	36.15	11.10	3.53	0.67	2.02	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	2.77	0.15	3.65	11.82	3.79	1.17
Natural Killer Cells, donor1	11230-116C6	7.69	0.31	5.23	20.30	3.38	0.92
Natural Killer Cells, donor2	11311-117C6	1.21	0.00	5.43	24.12	2.11	1.21
Natural Killer Cells, donor3	11387-118C1	4.42	0.37	2.94	20.06	1.84	0.55
Neural stem cells, donor1	11275-116H6	87.47	14.52	5.08	3.27	3.27	0.73
Neural stem cells, donor2	11352-117H2	77.03	5.78	5.78	1.93	5.78	0.00
Neurons, donor1	11494-119E9	59.17	11.38	7.97	0.00	3.41	1.14
Neurons, donor2	11574-120E8	46.01	11.67	8.37	1.10	2.20	0.22
Neurons, donor3	11655-122E8	61.66	4.11	6.58	1.64	2.47	0.00
Neutrophils, donor1	11233-116C9	27.84	1.86	3.71	43.62	8.35	1.86
Neutrophils, donor2	11314-117C9	11.60	8.70	0.00	28.99	0.00	0.00
Neutrophils, donor3	11390-118C4	50.09	5.50	4.28	80.02	12.83	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	19.83	5.34	7.84	0.59	0.83	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	25.72	4.23	6.84	1.63	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	11.83	5.41	5.01	0.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	40.88	7.02	3.44	0.14	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	38.65	7.09	2.61	0.43	0.29	0.00
Olfactory epithelial cells, donor3	11935-125I9	43.02	8.29	3.52	0.23	0.45	0.11
Olfactory epithelial cells, donor4	11936-126A1	26.78	3.90	4.29	0.19	0.68	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	29.49	8.43	2.41	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	16.80	2.77	3.83	0.43	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	9.14	2.29	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	11.17	2.48	5.59	0.00	1.24	0.00
Osteoblast, donor1	11277-116H8	20.72	2.74	2.15	0.59	0.39	0.00
Osteoblast, donor2	11354-117H4	44.95	8.43	1.40	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	25.42	5.87	3.38	0.89	1.24	0.00
Pancreatic stromal cells, donor1	11249-116E7	30.83	6.74	3.54	0.84	0.76	0.34
Pericytes, donor1	11491-119E6	21.25	3.45	3.67	0.22	0.78	0.22
Pericytes, donor2	11571-120E5	18.56	4.30	4.53	0.23	0.45	0.00
Pericytes, donor3	11652-122E5	27.47	3.26	1.63	0.81	0.20	0.20
Perineurial Cells, donor1	11499-119F5	38.99	7.91	4.29	1.13	1.36	0.11
Perineurial Cells, donor2	11579-120F4	35.33	8.28	3.31	0.55	0.37	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	31.87	2.87	5.42	28.37	3.51	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	24.24	2.69	4.65	14.20	1.71	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	18.25	0.91	4.79	15.53	1.42	0.52
Placental Epithelial Cells, donor1	11278-116H9	6.46	1.43	1.20	0.48	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	19.96	6.65	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	12.76	2.36	0.98	0.20	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	39.24	3.80	0.95	2.22	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	42.21	4.88	2.81	2.25	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	21.01	4.70	1.17	0.26	0.39	0.00
Preadipocyte - breast, donor2	11328-117E5	34.90	5.85	2.25	1.35	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	55.09	8.21	2.77	2.13	0.64	0.11
Preadipocyte - omental, donor2	11329-117E6	58.92	9.17	2.62	0.87	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	43.26	10.31	2.01	1.72	0.72	0.43
Preadipocyte - perirenal, donor1	11469-119C2	39.37	7.87	0.98	1.97	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	19.04	3.38	1.23	0.92	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	36.83	7.61	2.48	0.71	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	39.17	7.32	3.75	1.36	0.51	0.17
Preadipocyte - visceral, donor1	11280-116I2	38.19	8.57	3.82	1.49	0.93	0.09
Preadipocyte - visceral, donor2	11357-117H7	40.96	5.06	0.46	0.46	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	28.84	9.30	2.82	1.78	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	17.80	2.11	0.75	0.00	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	23.43	4.20	0.68	0.95	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	11.70	3.49	2.20	0.55	0.43	0.06
Prostate Stromal Cells, donor1	11254-116F3	26.54	5.70	2.73	0.80	0.46	0.11
Prostate Stromal Cells, donor2	11332-117E9	28.69	5.74	2.15	0.36	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	30.66	9.07	4.28	0.42	0.73	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	40.15	5.84	2.19	0.00	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	27.86	3.74	1.59	0.49	0.28	0.07
Renal Epithelial Cells, donor1	11517-119H5	35.00	6.09	1.01	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	36.99	4.27	2.13	2.85	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	34.30	4.34	1.80	0.85	0.32	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	38.81	4.77	0.68	2.72	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	43.26	5.79	2.02	0.94	0.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	48.18	9.77	1.11	1.33	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	25.29	0.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	52.60	7.04	2.20	1.10	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	39.50	5.02	1.88	0.00	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	25.80	0.83	1.39	0.00	0.28	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	47.24	6.17	1.61	0.54	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	24.88	2.53	1.69	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	41.46	6.94	0.77	0.39	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	42.00	11.93	4.41	1.04	1.04	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	47.75	11.37	3.13	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	37.05	4.12	3.09	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	31.87	3.51	4.01	0.25	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	53.32	14.03	7.22	1.47	0.94	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	80.41	2.68	1.79	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	68.25	6.60	4.40	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	73.67	2.90	6.38	0.58	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	74.50	9.88	2.47	0.52	0.65	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	47.77	6.26	1.99	0.20	0.20	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	73.17	7.81	2.01	0.33	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	64.50	12.28	4.09	0.74	0.99	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	57.92	7.23	1.86	0.12	0.47	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	67.49	8.32	3.70	1.16	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	58.05	8.90	2.46	0.14	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	49.01	7.87	1.97	0.45	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	64.87	10.75	2.51	0.18	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	65.85	9.61	2.30	0.72	0.72	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	45.18	6.76	1.61	0.21	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	56.42	9.07	2.43	0.22	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	57.93	11.09	1.72	0.19	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.00	8.11	1.96	0.47	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	82.30	6.58	2.44	0.38	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	53.08	9.42	2.26	0.40	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	46.24	7.01	1.75	0.58	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	59.39	8.98	1.72	1.15	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	57.35	10.25	2.56	0.43	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	44.57	5.89	1.40	0.28	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	64.43	8.03	1.88	0.17	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	50.32	7.66	2.19	0.55	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	48.07	6.74	0.74	0.37	0.49	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	53.73	8.87	1.88	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	65.34	11.79	1.42	0.47	1.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	50.40	6.94	1.19	0.60	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	58.70	5.61	2.34	0.47	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	60.76	10.99	3.32	0.21	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	57.74	5.31	0.88	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	54.94	6.06	2.09	0.00	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	59.22	13.59	1.21	0.13	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	37.29	4.09	2.21	0.68	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	48.58	8.10	1.54	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	70.15	14.79	3.09	0.00	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	42.39	8.50	1.37	0.41	1.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	58.12	9.19	2.63	0.33	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	72.77	12.10	2.90	0.51	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	60.22	10.95	2.52	0.59	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	65.04	6.93	2.40	0.27	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	52.96	8.71	1.94	0.69	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	54.76	8.57	2.38	0.00	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	67.72	8.87	2.82	0.40	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	67.33	7.35	2.54	0.19	0.57	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	65.33	7.69	1.75	0.00	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	66.79	8.16	3.63	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	83.22	9.67	3.18	0.61	0.73	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	126.63	13.68	4.37	0.58	1.31	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	68.75	14.60	3.65	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	83.79	10.85	1.51	0.30	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	62.43	9.95	3.17	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	72.79	10.18	5.39	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	64.70	8.27	2.36	0.12	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	40.34	5.98	1.71	0.43	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	73.32	5.41	1.20	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	29.34	6.58	2.44	0.38	0.19	0.19
Schwann Cells, donor2	11578-120F3	27.22	3.40	0.00	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	31.55	6.35	1.75	0.66	0.00	0.00
Sebocyte, donor1	11220-116B5	18.08	2.74	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	18.84	4.60	1.38	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	14.43	5.15	1.65	0.62	0.21	0.00
Sertoli Cells, donor1	11255-116F4	54.67	3.31	3.31	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	45.19	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	21.03	3.08	2.02	0.35	0.44	0.00
Skeletal Muscle Cells, donor2	11358-117H8	6.51	0.72	2.17	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	19.23	1.67	0.84	2.51	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	28.75	7.85	3.61	0.94	0.47	0.00
Skeletal Muscle Cells, donor5	11455-119A6	26.90	7.13	2.53	1.19	0.74	0.00
Skeletal Muscle Cells, donor6	11459-119B1	30.01	5.69	2.62	2.31	0.31	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	39.82	10.58	6.43	0.88	0.88	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	32.10	7.71	4.14	0.57	0.71	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	33.83	6.75	2.28	0.89	0.30	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	25.61	3.71	2.86	0.51	0.59	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.03	0.72	1.45	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.60	3.44	1.24	0.00	0.14	0.00
Skin - palm, donor1	10286-104F7	16.12	2.69	8.06	0.00	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	23.50	3.17	0.72	0.72	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	79.34	9.81	1.64	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	32.20	3.89	0.39	0.39	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	37.81	4.03	1.67	0.56	0.14	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	24.76	4.50	0.84	0.70	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	52.02	15.22	2.33	0.42	0.42	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	21.51	5.17	1.35	0.22	0.30	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	48.76	12.34	5.86	0.62	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.23	4.45	1.56	0.44	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	3.53	4.11	1.18	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	15.69	4.42	0.66	0.44	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	22.05	5.91	0.39	0.00	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	25.49	5.41	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	27.02	5.00	12.01	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	22.49	2.66	1.20	1.33	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	57.19	17.07	6.87	1.11	1.11	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	36.62	9.86	1.92	1.15	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	32.56	6.84	3.91	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	50.80	10.34	3.25	1.48	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	30.75	6.69	1.71	0.43	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	18.22	2.60	2.28	0.98	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.92	3.65	3.35	0.30	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	19.19	5.30	2.53	0.51	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	18.60	1.43	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	25.81	6.78	3.69	0.44	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.42	7.53	3.23	0.22	1.29	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	31.91	7.35	2.62	0.63	0.42	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	14.54	3.56	0.93	0.46	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	25.87	4.31	0.00	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.33	4.48	1.49	1.20	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	32.77	2.73	1.37	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	37.93	7.77	5.89	0.39	0.71	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	30.29	5.54	2.92	1.91	0.81	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	35.95	8.42	1.37	0.46	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	14.49	3.02	1.21	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	45.04	11.13	4.77	0.53	1.06	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	37.28	10.92	2.93	1.33	0.67	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	36.81	12.52	3.01	2.00	0.38	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	33.23	7.36	8.88	1.27	1.52	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	25.63	4.67	3.02	0.75	1.36	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	16.50	4.50	2.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	14.21	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.00	1.40	0.47	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	43.92	6.06	1.51	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	35.73	3.13	0.94	1.88	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	19.76	8.85	3.83	0.59	1.18	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	24.66	8.16	4.42	0.75	1.42	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	13.08	5.14	4.20	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	32.53	4.03	0.72	1.58	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	26.52	4.59	2.04	0.76	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	18.24	4.32	1.50	0.38	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	42.76	9.50	2.66	0.56	0.70	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	28.74	6.20	2.43	0.75	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	0.95	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	26.67	8.56	1.22	1.71	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	38.89	9.94	3.31	0.44	1.10	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	26.33	6.73	4.97	1.46	1.17	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	25.66	2.53	4.47	0.58	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	32.79	4.50	0.79	1.06	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	17.85	5.95	6.32	1.12	1.49	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	28.03	6.11	5.03	0.72	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	27.82	4.83	1.99	0.85	1.42	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	40.96	4.33	2.36	0.00	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	23.11	2.79	4.83	0.00	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	22.76	3.99	3.19	0.00	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	18.39	2.93	2.51	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	15.58	3.21	2.75	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	50.50	7.74	3.53	1.68	0.67	0.00
Synoviocyte, donor2	11368-117I9	20.79	6.54	3.86	0.67	0.50	0.00
Synoviocyte, donor3	11440-118H9	24.13	8.94	2.68	0.00	1.12	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	35.02	6.79	1.07	1.07	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	33.69	5.95	0.00	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	26.40	3.24	1.16	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	13.76	2.37	1.72	0.43	0.29	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	11.60	2.71	0.00	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	1.72	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	49.33	13.04	7.87	1.60	1.85	0.37
Urethra, donor2	10319-105A4	19.78	1.80	3.60	3.60	3.60	0.00
Urothelial Cells, donor1	11520-119H8	16.21	2.66	1.06	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	13.22	2.40	1.20	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	9.86	1.15	0.23	0.00	0.46	0.00
Urothelial cells, donor0	11216-116B1	14.71	4.90	3.57	0.45	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	53.39	3.56	13.35	43.60	8.01	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	71.48	4.29	12.87	50.04	7.15	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	36.28	8.21	11.64	21.22	3.42	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	21.35	2.07	7.58	29.61	6.89	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	39.51	4.07	9.30	38.93	6.97	2.91
Whole blood (ribopure), donor090612, donation1	12182-129A4	76.01	6.25	14.58	44.77	8.33	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	64.25	3.67	16.52	38.55	7.34	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	30.13	2.74	8.22	32.86	6.39	0.00
Wilms' tumor cell line:G-401	10809-111A8	26.28	7.03	3.33	1.36	0.99	0.00
Wilms' tumor cell line:HFWT	10597-108E3	14.08	4.40	2.64	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	19.55	3.91	1.68	0.84	0.28	0.00
achilles tendon, donor2	10292-104G4	16.53	0.00	6.20	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1.53	1.27	3.82	16.57	2.29	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1.39	0.46	9.98	21.36	5.34	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	5.82	1.66	8.90	29.91	7.60	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	6.26	0.54	3.27	15.24	4.08	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1.41	0.00	1.97	4.50	1.69	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	21.57	2.75	5.71	8.46	5.71	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	17.69	1.36	2.99	4.36	1.36	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	24.24	1.76	3.08	4.41	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	17.15	0.82	6.94	9.39	5.31	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	1.94	0.00	1.16	7.38	1.16	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.06	0.74	2.02	5.52	1.66	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	74.11	7.80	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	18.82	0.93	3.25	1.86	1.86	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	7.25	0.26	5.18	8.28	3.62	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	2.63	0.58	1.75	3.51	2.05	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	21.84	2.79	1.86	17.20	2.32	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	61.69	2.06	0.82	2.06	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	40.21	6.14	1.53	0.92	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	73.82	16.21	3.41	7.68	1.71	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	88.56	13.34	4.85	5.46	3.34	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	78.23	16.37	3.61	6.26	1.93	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	14.48	1.11	2.00	9.80	4.45	2.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	28.02	4.00	1.67	2.67	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	1.86	1.86	1.86	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	16.20	1.51	1.51	4.90	2.26	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	28.78	0.87	0.87	1.74	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	1.87	3.75	5.62	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	54.40	8.48	6.83	0.47	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	40.02	5.27	8.22	0.31	1.71	0.00
adipose, donor1	10184-103D4	165.37	26.97	12.90	2.35	1.17	0.59
adipose, donor2	10185-103D5	40.55	4.87	4.06	0.41	0.41	0.00
adipose, donor3	10186-103D6	66.71	8.71	3.27	1.09	0.00	0.00
adipose, donor4	10187-103D7	40.74	7.80	4.33	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	4.89	3.31	8.84	2.84	2.84	0.63
adrenal gland, adult, pool1	10081-102A9	7.28	7.28	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	7.20	1.20	6.14	3.47	4.54	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	37.87	5.00	3.22	0.36	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	18.08	4.87	5.33	0.23	2.09	0.00
amniotic membrane cells, donor2	12236-129G4	29.75	8.11	3.72	1.01	1.35	0.34
amniotic membrane cells, donor3	12237-129G5	14.73	5.60	7.37	0.00	0.88	0.00
amygdala - adult, donor10196	10167-103B5	36.76	18.97	13.04	1.19	9.49	3.56
amygdala, adult, donor10252	10151-102I7	42.78	20.28	29.60	1.82	7.91	0.20
amygdala, newborn, donor10223	10360-105E9	31.31	4.20	12.59	0.65	7.10	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	141.46	12.10	9.93	0.89	1.66	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	9.27	1.54	1.10	1.99	0.44	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	97.87	11.69	5.01	0.00	0.33	0.00
aorta, adult, pool1	10052-101G7	16.67	7.65	4.12	0.00	0.98	0.00
appendix, adult	10189-103D9	11.64	3.49	5.05	10.09	1.55	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	41.62	9.63	8.60	2.75	1.72	0.00
artery, adult	10190-103E1	9.51	2.72	9.51	8.15	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	190.07	38.53	7.68	3.91	0.72	0.14
b cell line:RPMI1788	10427-106D4	1.93	1.19	3.12	12.19	1.19	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	77.13	17.20	2.22	3.05	1.94	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	48.82	7.44	1.79	0.79	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	19.58	5.02	2.51	0.50	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	10.07	0.56	5.59	1.68	1.68	0.00
bladder, adult, pool1	10011-101C2	35.63	7.93	14.56	1.63	1.96	0.22
blood, adult, pool1	10053-101G8	13.29	4.43	8.86	22.15	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	104.47	19.70	1.71	2.57	0.86	0.00
bone marrow, adult	10192-103E3	57.36	5.40	3.37	2.02	0.67	0.00
brain, adult, donor1	10084-102B3	18.45	5.13	10.25	1.03	3.08	1.03
brain, adult, pool1	10012-101C3	34.19	9.02	19.93	2.12	9.80	0.33
brain, fetal, pool1	10085-102B4	32.06	10.69	21.37	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	38.98	4.29	5.29	0.33	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	27.59	5.74	6.37	0.62	1.25	0.00
breast, adult, donor1	10080-102A8	37.88	7.58	5.05	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.65	2.29	0.13	0.38	0.13	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	72.98	8.97	6.80	0.62	1.24	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	37.30	11.74	29.24	3.91	4.83	2.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	8.23	2.42	2.91	1.94	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	16.46	1.88	1.88	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	24.50	5.80	2.08	0.88	0.44	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	22.50	2.85	5.39	0.32	1.90	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	31.14	7.72	21.56	0.53	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	54.11	10.36	18.42	10.36	10.36	0.00
caudate nucleus, adult, donor10252	10164-103B2	50.87	24.76	26.10	2.34	8.53	0.17
caudate nucleus, adult, donor10258	10379-105H1	64.19	9.17	22.92	1.53	8.41	0.76
caudate nucleus, newborn, donor10223	10354-105E3	39.92	5.86	13.55	1.46	5.86	0.73
cerebellum - adult, donor10196	10173-103C2	93.22	20.39	26.22	0.00	23.31	0.00
cerebellum, adult, donor10252	10166-103B4	56.79	19.64	22.85	2.35	7.47	0.21
cerebellum, adult, pool1	10083-102B2	22.42	8.28	11.38	1.72	5.17	0.34
cerebellum, newborn, donor10223	10357-105E6	82.20	11.62	29.06	0.83	3.32	0.00
cerebral meninges, adult	10188-103D8	33.79	9.58	16.39	1.76	4.29	0.76
cerebrospinal fluid, donor2	10294-104G6	35.81	2.92	13.16	5.12	1.46	1.46
cervical cancer cell line:D98-AH2	10552-107I3	81.24	9.92	8.20	0.72	0.86	0.14
cervical cancer cell line:ME-180	10553-107I4	46.07	10.77	4.14	0.50	0.66	0.00
cervix, adult, pool1	10013-101C4	34.65	7.14	13.54	1.36	1.05	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	127.49	23.41	6.55	3.34	1.53	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	20.90	1.31	2.61	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	22.37	2.36	0.75	0.87	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	19.34	7.39	4.19	1.72	0.37	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	20.40	2.85	0.47	0.47	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	13.96	4.56	1.99	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	33.61	9.45	2.09	0.40	0.60	0.00
chorionic membrane cells, donor3	12240-129G8	21.43	3.30	0.55	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	15.15	3.03	8.08	27.26	5.05	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	12.49	0.77	2.50	3.46	1.54	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	6.97	2.53	1.06	2.11	0.21	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.37	2.57	1.03	0.51	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	26.12	3.63	2.18	1.45	0.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.97	3.46	1.83	1.63	1.22	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	15.61	3.53	1.47	2.65	1.47	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	7.30	1.30	2.61	4.43	1.30	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	28.34	5.03	2.51	0.00	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	10.58	3.30	1.56	0.17	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	19.22	3.84	0.37	0.37	0.37	0.00
colon carcinoma cell line:COLO-320	10420-106C6	122.39	12.16	20.52	0.00	3.42	0.38
colon, adult, donor1	10082-102B1	27.37	3.57	1.19	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	35.49	10.69	7.99	1.76	1.88	0.12
colon, fetal, donor1	10070-101I7	40.17	4.94	6.18	2.47	3.71	0.00
common myeloid progenitor CMP, donor1	12130-128D6	0.00	0.00	18.33	22.92	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	25.04	25.04	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	15.72	2.97	1.70	4.25	3.40	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	13.89	1.96	2.26	3.92	2.87	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	13.26	3.81	2.12	6.63	2.96	0.85
corpus callosum, adult, pool1	10042-101F6	32.39	10.95	18.24	3.54	6.08	0.44
cruciate ligament, donor2	10295-104G7	21.07	5.67	8.10	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	23.27	6.42	4.01	4.82	2.41	0.00
diencephalon, adult	10193-103E4	42.00	12.72	12.96	3.12	6.72	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.23	0.23	0.92	17.22	1.61	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	33.34	4.62	2.82	0.77	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	20.46	4.81	8.43	0.96	0.72	0.72
ductus deferens, adult	10196-103E7	45.85	11.96	10.47	0.50	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	11.52	5.76	1.44	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	59.59	7.36	8.09	2.21	2.21	0.00
dura mater, adult, donor1	10041-101F5	37.25	6.19	8.67	2.64	1.24	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	29.54	2.89	0.44	0.67	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	39.84	8.02	3.30	2.01	1.15	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	37.00	11.10	3.08	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	39.35	7.87	6.96	0.91	1.21	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	43.22	8.95	4.32	0.00	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	30.21	13.13	3.94	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	11.06	3.35	2.01	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	27.19	9.24	10.15	1.45	1.09	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	37.15	13.03	6.43	1.61	1.45	0.64
epidermoid carcinoma cell line:A431	10426-106D3	23.23	2.78	1.45	0.44	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	36.41	2.20	1.32	0.66	0.33	0.00
epididymis, adult	10197-103E8	41.23	12.14	15.28	0.84	2.09	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	22.35	9.05	7.98	0.71	2.31	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.58	3.15	1.18	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	21.10	6.29	0.92	0.52	0.13	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	25.10	6.20	0.98	0.49	0.30	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	24.53	5.04	1.12	0.45	0.34	0.00
esophagus, adult, pool1	10015-101C6	35.78	7.64	5.63	1.81	1.17	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	15.65	5.64	19.29	0.25	1.75	0.00
eye - muscle inferior rectus, donor1	10272-104E2	19.32	12.07	7.24	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	2.10	0.00	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	11.91	1.49	8.93	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	18.34	2.29	9.17	1.15	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	16.03	7.29	18.95	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	37.88	10.42	15.76	2.29	3.81	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	74.50	14.23	3.33	2.05	0.51	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	14.25	2.14	1.42	0.47	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	38.66	14.73	27.49	2.25	11.35	0.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	51.64	15.61	3.30	0.30	1.20	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	23.41	3.11	2.01	0.27	0.18	0.09
gall bladder, adult	10198-103E9	25.11	5.79	4.83	1.45	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	2.15	0.00	5.37	27.92	5.91	0.00
gamma delta positive T cells, donor2	11938-126A3	6.35	1.12	4.48	23.53	4.11	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.43	4.01	2.11	0.63	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	7.74	3.67	2.51	0.19	1.16	0.19
gastric cancer cell line:AZ521	10549-107H9	25.90	13.44	19.84	2.95	6.72	0.33
gastric cancer cell line:GSS	10560-108A2	9.15	1.83	1.83	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	11.19	2.74	0.69	0.23	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	23.18	3.90	1.84	0.00	0.34	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	41.85	5.74	5.74	0.70	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	7.23	1.75	0.50	0.25	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	54.68	8.34	2.96	0.95	1.06	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	53.23	10.53	3.65	0.98	1.54	0.28
glioblastoma cell line:T98G	10485-107A8	41.28	5.96	3.20	0.66	0.44	0.11
glioma cell line:GI-1	10413-106B8	29.58	5.27	2.34	0.59	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	88.93	21.14	32.80	1.46	7.29	0.73
globus pallidus, adult, donor10252	10161-103A8	62.98	29.78	37.35	3.91	10.01	1.95
globus pallidus, adult, donor10258	10367-105F7	110.91	15.06	24.65	2.74	8.22	1.37
globus pallidus, newborn, donor10223	10364-105F4	41.57	3.73	12.26	1.60	5.33	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	9.79	0.00	4.89	2.45	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	21.86	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	0.00	0.00	15.68	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	35.20	3.84	0.96	0.64	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	47.75	14.23	2.75	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	46.18	6.86	2.74	0.46	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	61.83	10.31	1.29	1.29	0.00	0.00
hIPS, biol_rep1	14380-156B6	73.30	5.75	2.87	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	63.10	8.92	0.00	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	52.97	7.72	14.35	1.10	9.93	1.10
hairy cell leukemia cell line:Mo	10712-109I1	0.86	1.44	2.01	10.34	0.29	0.29
heart - mitral valve, adult	10205-103F7	22.12	6.58	9.87	0.90	2.99	0.30
heart - pulmonic valve, adult	10206-103F8	21.70	4.97	8.63	2.35	3.14	0.00
heart - tricuspid valve, adult	10207-103F9	14.15	0.83	3.33	0.83	2.50	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	8.98	4.29	5.10	1.43	0.61	0.20
heart, adult, diseased, donor1	10051-101G6	17.03	0.85	2.98	2.98	0.85	0.00
heart, adult, pool1	10016-101C7	17.71	4.83	8.74	3.22	2.53	0.46
heart, fetal, pool1	10046-101G1	44.56	8.32	10.47	3.18	3.70	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	71.27	13.27	3.39	1.23	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	22.59	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	56.79	7.85	2.87	0.88	0.22	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	55.35	9.47	2.31	0.97	0.49	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	57.50	10.41	2.93	0.61	0.10	0.10
hepatoma cell line:Li-7	10484-107A7	30.14	5.00	0.89	0.22	0.33	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	17.79	3.12	2.91	5.23	1.61	0.30
hippocampus - adult, donor10196	10169-103B7	40.69	9.46	21.77	0.95	13.25	0.95
hippocampus, adult, donor10252	10153-102I9	44.90	23.27	26.53	4.08	10.20	0.82
hippocampus, adult, donor10258	10374-105G5	58.26	11.45	7.97	2.49	4.98	0.50
hippocampus, newborn, donor10223	10363-105F3	21.50	3.88	10.22	0.70	3.52	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	78.12	12.21	6.10	4.27	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	39.86	5.11	1.77	1.57	0.59	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	47.22	5.59	2.03	1.02	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	49.06	2.82	5.07	1.13	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	41.57	3.61	5.16	0.77	0.77	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	45.93	4.56	3.80	1.52	1.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	52.84	6.71	3.80	0.00	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	44.38	5.60	3.88	0.43	0.43	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.47	4.59	3.34	0.00	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	78.62	14.92	5.21	1.66	0.47	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	64.93	11.57	2.09	0.96	0.32	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	75.41	16.16	4.04	3.37	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	31.30	5.16	1.88	1.56	0.47	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	41.76	5.40	2.46	0.49	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	54.11	3.49	2.62	4.36	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	64.15	6.30	3.05	1.53	0.76	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	64.97	9.59	3.92	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	125.44	6.50	4.00	1.50	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	28.64	4.52	5.27	0.19	1.13	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	50.93	5.91	3.64	1.36	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	47.61	5.95	4.70	0.63	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	84.26	11.92	4.41	1.47	0.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	84.77	12.48	2.61	2.61	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	93.56	11.36	4.18	1.79	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	39.54	5.54	2.22	1.66	0.55	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	47.07	7.42	2.85	0.86	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	66.96	10.62	3.27	1.63	0.82	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	66.19	8.45	2.82	1.41	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	60.50	8.24	3.48	0.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	62.95	6.66	2.72	0.30	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	53.78	6.21	2.59	1.03	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	46.49	5.31	1.99	1.33	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	54.38	4.10	4.62	0.51	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	85.39	10.74	5.62	3.07	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	95.41	12.87	2.27	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	107.20	12.43	2.69	5.04	0.67	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	42.02	5.80	2.17	1.69	0.48	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	63.28	3.57	1.34	1.78	1.34	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	51.71	5.85	4.39	0.00	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	55.32	6.72	2.44	1.22	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	136.64	26.03	22.77	9.76	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	68.51	3.31	5.30	1.99	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	44.88	7.66	2.19	0.55	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	57.90	4.34	4.70	0.36	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	42.35	7.83	1.42	0.36	1.07	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	95.47	9.55	3.58	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	112.81	17.06	5.82	2.71	1.63	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	106.68	13.20	4.85	4.04	0.54	0.27
immature langerhans cells, donor1	11904-125F5	33.90	0.97	0.00	0.48	0.24	0.00
immature langerhans cells, donor2	11905-125F6	16.63	0.79	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	30.76	9.56	20.35	1.99	8.14	0.66
keratoacanthoma cell line:HKA-1	10791-110H8	26.34	7.15	1.30	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	47.66	15.32	9.01	1.50	1.30	0.10
kidney, fetal, pool1	10045-101F9	40.60	11.46	10.33	1.13	1.63	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	17.75	3.12	1.85	0.14	0.57	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	25.57	4.70	2.63	0.41	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	39.27	5.87	3.67	0.37	0.18	0.00
left atrium, adult, donor1	10079-102A7	26.70	3.81	7.63	5.99	2.72	0.00
left ventricle, adult, donor1	10078-102A6	17.19	2.53	4.55	2.02	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	9.58	4.65	4.38	0.82	1.64	0.00
leiomyoma cell line:10964C	10569-108B2	28.02	9.70	3.95	0.72	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	32.61	9.24	2.17	2.17	0.54	0.00
leiomyoma cell line:15425	10571-108B4	30.11	7.53	3.40	1.21	0.97	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	12.70	6.35	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	35.55	7.32	2.09	1.05	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	25.97	2.24	3.07	2.13	1.18	0.00
liposarcoma cell line:KMLS-1	10782-110G8	84.51	16.71	7.19	1.25	0.31	0.00
liposarcoma cell line:SW 872	10726-110A6	25.22	5.24	3.17	0.85	0.37	0.00
liver, adult, pool1	10018-101C9	26.25	6.32	2.43	0.49	0.49	0.00
liver, fetal, pool1	10086-102B5	10.35	4.70	0.00	0.00	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	33.83	7.15	18.52	3.79	6.12	0.73
locus coeruleus, adult, donor10252	10165-103B3	41.89	20.85	25.28	2.21	7.75	0.55
locus coeruleus, adult, donor10258	10375-105G6	32.16	5.08	12.70	1.69	4.80	0.28
locus coeruleus, newborn, donor10223	10362-105F2	34.91	7.99	10.52	2.94	5.05	0.84
lung adenocarcinoma cell line:A549	10499-107C4	25.46	6.37	2.63	0.42	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	38.61	7.58	1.38	1.38	3.45	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	23.07	2.90	2.77	0.13	0.40	0.13
lung, adult, pool1	10019-101D1	35.56	6.50	8.51	3.78	2.36	0.12
lung, fetal, donor1	10068-101I5	63.08	9.13	10.56	3.42	3.42	0.29
lung, right lower lobe, adult, donor1	10075-102A3	23.37	4.58	4.58	1.83	2.75	0.46
lymph node, adult, donor1	10077-102A5	9.47	3.31	2.37	12.31	0.95	1.42
lymphangiectasia cell line:DS-1	10727-110A7	0.44	0.22	1.75	5.04	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	2.11	0.75	2.87	14.49	3.02	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	32.28	3.40	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	67.04	20.42	12.43	0.00	1.33	0.00
mature adipocyte, donor2	12232-129F9	96.50	31.75	16.60	1.25	2.49	0.21
mature adipocyte, donor3	12233-129G1	108.57	30.82	13.28	1.42	4.50	0.00
mature adipocyte, donor4	12234-129G2	73.44	23.69	18.16	0.79	2.63	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	22.16	5.00	6.19	3.57	2.14	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	67.68	11.28	14.66	1.13	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	44.69	21.15	24.46	3.31	8.83	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	59.09	10.80	18.74	2.54	6.99	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	44.78	6.40	28.15	1.28	14.07	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	47.08	10.63	23.96	2.70	10.63	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	58.15	15.92	22.92	2.97	8.28	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	123.28	9.63	17.34	7.71	7.71	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	43.06	114.83	0.00	86.12	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	30.87	6.10	11.13	0.72	4.31	0.36
medulla oblongata - adult, donor10196	10174-103C3	59.06	15.58	14.93	1.95	3.89	0.65
medulla oblongata, adult, donor10252	10155-103A2	45.98	19.97	22.14	3.25	4.33	0.46
medulla oblongata, adult, pool1	10038-101F2	21.47	7.67	16.00	1.96	4.57	0.57
medulla oblongata, newborn, donor10223	10361-105F1	31.94	6.94	9.72	1.39	3.12	0.00
medulloblastoma cell line:D283 Med	10838-111E1	50.70	12.18	7.75	0.89	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	22.99	4.52	0.73	0.12	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	63.54	8.34	2.16	0.86	1.01	0.00
melanoma cell line:G-361	10465-106H6	19.00	2.44	1.63	0.00	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	15.02	3.08	1.63	0.00	0.18	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	114.55	12.34	7.93	2.64	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	37.33	13.74	7.00	2.85	3.89	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	32.99	8.59	5.98	1.23	0.92	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	31.08	10.36	4.54	0.18	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	35.61	5.38	3.73	0.41	1.66	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	16.44	5.76	3.65	0.28	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.23	8.67	6.55	0.19	0.77	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.82	6.25	4.16	2.08	2.08	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	28.66	9.10	3.78	0.51	1.03	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.01	6.33	3.34	0.35	0.46	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.16	9.28	2.65	1.19	0.13	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	23.90	6.48	2.03	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	32.86	9.82	2.42	1.00	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	25.03	3.62	1.98	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	38.74	8.72	2.35	0.97	0.97	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	22.34	4.54	0.70	0.35	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.17	7.55	3.06	0.82	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.53	3.95	2.88	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	40.86	8.28	2.48	0.93	0.62	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	28.95	7.07	2.05	0.91	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	36.50	7.97	3.36	2.94	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	38.70	8.97	1.94	0.30	0.75	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	41.75	12.08	3.06	1.14	0.09	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	32.03	5.52	2.21	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	21.46	2.58	1.14	0.00	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	61.05	8.84	5.05	1.68	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	31.51	8.22	2.74	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	26.86	9.21	4.60	0.77	1.53	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	28.01	7.85	4.45	0.00	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	20.95	5.24	4.93	0.00	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	27.30	5.65	4.47	0.47	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	27.75	6.77	3.72	0.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	27.12	5.11	3.54	1.57	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	32.44	2.78	4.17	0.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	32.01	7.79	5.77	1.44	1.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	26.10	6.92	2.01	0.67	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	29.08	4.57	2.88	0.00	0.48	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	41.07	8.07	5.87	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.50	5.71	3.02	0.00	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	22.11	3.68	3.28	0.41	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	27.06	3.44	3.87	0.86	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	2.73	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	5.16	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	27.61	9.42	3.57	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	32.01	4.36	5.82	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	35.72	8.53	2.67	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	6.54	4.09	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	28.77	2.72	3.50	0.78	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	35.68	6.30	6.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	25.83	1.99	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	9.53	0.00	0.00	4.77	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.94	2.37	4.74	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	17.06	3.66	2.44	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	29.77	8.23	3.17	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	39.32	6.55	4.48	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	4.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	3.44	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	41.15	6.52	4.89	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.13	8.74	6.36	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.99	9.43	8.25	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	31.48	6.23	5.30	0.00	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	32.08	9.36	4.01	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	2.37	5.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	5.14	2.57	0.00	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.72	9.64	8.26	0.69	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	42.06	7.42	6.43	0.49	2.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	45.98	4.49	10.09	3.36	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	40.71	3.18	5.72	1.91	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	48.36	8.46	12.49	0.81	1.61	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	43.61	13.08	17.44	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	49.42	5.07	10.14	1.27	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	32.77	13.96	12.74	3.03	3.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	27.11	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	37.07	8.24	6.59	0.00	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	44.65	11.71	6.35	0.99	0.99	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	34.07	7.79	6.49	0.00	0.97	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	30.56	7.13	4.07	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	59.58	11.61	4.64	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	35.20	19.84	9.92	1.89	1.18	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	39.62	7.88	1.62	0.70	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	4.27	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	118.16	14.80	1.64	1.03	0.10	0.00
mesothelioma cell line:Mero-25	10850-111F4	111.89	15.89	1.13	3.18	0.68	0.45
mesothelioma cell line:Mero-41	10851-111F5	24.69	3.18	1.47	0.24	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	114.92	14.84	1.55	1.55	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	44.15	4.47	1.31	0.53	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	149.79	15.15	2.55	1.53	0.34	0.17
mesothelioma cell line:Mero-84	10855-111F9	30.33	4.04	0.76	0.51	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	68.53	4.76	0.62	0.41	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	28.16	2.65	0.50	0.50	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	62.99	7.06	1.81	1.45	0.54	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	75.16	9.91	3.59	1.71	1.02	0.17
mesothelioma cell line:NCI-H28	10845-111E8	45.04	9.92	2.04	0.51	0.51	0.00
mesothelioma cell line:No36	10857-111G2	47.95	5.55	1.30	1.30	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	31.16	1.08	0.54	0.00	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	5.95	1.54	0.19	1.73	0.58	0.19
migratory langerhans cells, donor2	11902-125F3	2.44	0.49	0.37	0.85	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	11.67	1.44	1.08	1.08	1.08	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	19.26	3.59	0.00	0.33	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	10.38	5.51	1.27	0.21	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	31.56	5.07	0.69	0.00	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.23	1.33	4.38	5.52	1.14	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	53.59	11.46	7.95	4.80	4.44	0.18
myeloma cell line:PCM6	10474-106I6	3.36	0.79	9.29	5.53	5.14	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	116.68	17.25	2.54	2.03	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	22.36	3.33	2.94	0.39	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	25.40	8.02	2.79	0.89	0.78	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	26.47	8.31	4.04	0.96	0.51	0.15
nasal epithelial cells, donor2	12227-129F4	23.74	7.18	2.21	0.00	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	129.98	24.39	15.87	0.46	2.53	0.00
neuroblastoma cell line:NB-1	10539-107G8	70.91	13.10	7.30	1.12	1.50	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	33.11	9.07	1.69	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	52.92	8.76	6.34	0.37	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	26.57	5.22	4.98	0.24	0.71	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	19.64	4.43	5.70	0.63	0.79	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	30.59	6.44	9.26	0.20	0.81	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	24.16	1.91	1.27	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	54.30	9.32	3.19	1.33	0.00	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	59.50	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	0.00	26.56	13.28	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	18.94	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.00	0.17	1.18	17.08	3.38	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	38.42	12.01	3.20	0.80	4.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	24.37	2.89	5.45	0.64	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	33.37	7.62	2.89	0.00	0.79	0.00
nucleus accumbens, adult, pool1	10037-101F1	35.43	16.22	25.78	1.87	10.50	0.37
occipital cortex - adult, donor10196	10172-103C1	78.29	12.36	20.60	8.24	12.36	0.00
occipital cortex, adult, donor10252	10163-103B1	66.82	22.01	29.52	3.22	11.81	0.27
occipital cortex, newborn, donor10223	10355-105E4	30.94	5.82	12.37	0.36	3.64	0.73
occipital lobe, adult, donor1	10076-102A4	38.84	11.28	18.37	1.57	4.20	0.26
occipital lobe, fetal, donor1	10073-102A1	56.21	17.16	30.04	1.72	4.29	0.86
occipital pole, adult, pool1	10036-101E9	28.07	10.01	13.01	1.97	4.97	0.32
olfactory region, adult	10195-103E6	26.75	10.51	17.58	1.91	5.35	0.38
optic nerve, donor1	10277-104E7	42.02	4.00	16.01	4.00	16.01	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	50.23	9.91	3.42	0.34	0.23	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	30.64	5.63	6.05	0.41	0.96	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.93	2.54	0.68	0.00	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	24.03	4.16	2.89	0.23	0.12	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	27.34	4.41	1.18	0.29	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	46.72	10.28	6.54	0.00	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	33.08	5.51	3.18	0.00	0.42	0.00
ovary, adult, pool1	10020-101D2	30.84	6.11	19.74	0.87	0.61	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	46.75	3.67	2.93	0.73	0.00	0.00
pancreas, adult, donor1	10049-101G4	15.99	9.41	11.29	1.88	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	40.81	6.15	1.40	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	61.84	8.01	2.73	1.53	0.68	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	29.80	3.48	1.32	0.00	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	33.68	11.44	21.05	2.38	8.60	0.55
parietal cortex, adult, donor10258	10373-105G4	41.10	9.54	16.88	7.34	6.61	0.73
parietal lobe - adult, donor10196	10171-103B9	45.14	14.11	23.51	2.82	4.70	0.00
parietal lobe, adult, donor10252	10157-103A4	47.03	17.39	29.93	3.42	7.70	0.57
parietal lobe, adult, pool1	10034-101E7	29.08	12.07	18.68	2.47	9.16	0.26
parietal lobe, fetal, donor1	10072-101I9	40.73	7.76	20.37	1.94	6.79	2.91
parietal lobe, newborn, donor10223	10356-105E5	34.40	6.36	15.70	1.87	5.98	1.87
parotid gland, adult	10199-103F1	14.80	6.78	8.63	5.55	1.85	0.00
penis, adult	10200-103F2	23.63	6.45	12.89	2.69	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	13.95	2.42	6.69	0.74	1.49	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	36.42	4.37	1.46	0.44	0.15	0.00
pineal gland - adult, donor10196	10179-103C8	27.09	10.32	10.97	1.29	3.23	0.65
pineal gland, adult, donor10252	10160-103A7	45.60	11.84	24.87	5.33	14.21	1.78
pineal gland, adult, donor10258	10377-105G8	40.13	5.02	12.54	4.39	6.27	0.63
pituitary gland - adult, donor10196	10180-103C9	126.48	34.40	38.45	3.04	8.09	2.02
pituitary gland, adult, donor10252	10162-103A9	147.49	45.34	56.81	2.08	10.42	0.52
pituitary gland, adult, donor10258	10378-105G9	104.70	31.50	28.94	3.40	5.11	0.00
placenta, adult, pool1	10021-101D3	21.82	4.84	3.01	0.86	0.97	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	3.18	0.53	1.99	8.87	2.65	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	44.98	5.45	1.71	0.16	0.47	0.00
pons, adult, pool1	10033-101E6	29.35	9.21	18.93	3.44	7.49	0.95
postcentral gyrus, adult, pool1	10032-101E5	28.07	11.25	17.78	1.66	6.97	0.78
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	0.00	4.18	2.09	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	5.51	5.51	22.03	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	11.74	58.68	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	97.45	24.33	11.51	3.79	3.79	0.29
prostate cancer cell line:PC-3	10439-106E7	34.49	6.72	3.99	0.36	1.09	0.00
prostate, adult, pool1	10022-101D4	37.73	12.70	12.15	1.36	2.27	0.09
putamen, adult, donor10196	10176-103C5	46.98	23.84	46.74	1.42	10.15	1.18
putamen, adult, donor10252	10152-102I8	68.63	21.57	43.14	5.88	13.73	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	85.24	5.46	8.74	4.37	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	46.63	13.29	22.71	1.69	6.52	0.72
putamen, newborn, donor10223	10365-105F5	46.48	9.75	22.49	4.50	6.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	23.57	2.91	2.04	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	33.38	11.13	9.74	0.00	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	28.41	3.60	1.70	0.00	0.42	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.61	6.21	2.07	0.00	0.83	0.00
retina, adult, pool1	10030-101E3	41.05	13.32	17.79	2.29	2.39	0.30
retinoblastoma cell line:Y79	10475-106I7	59.75	10.13	11.95	2.34	1.04	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	26.19	8.11	4.30	0.98	0.74	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	31.78	12.65	9.00	0.28	1.69	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.95	4.55	3.79	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	12.30	3.72	3.56	0.32	0.49	0.00
salivary acinar cells, donor2	11772-123I8	19.55	5.78	4.13	0.41	0.69	0.00
salivary acinar cells, donor3	11773-123I9	19.20	5.30	7.94	0.66	1.32	0.00
salivary gland, adult, pool1	10093-102C3	32.03	4.00	5.72	2.29	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	23.69	3.71	2.28	0.42	0.51	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	22.57	6.23	3.64	0.12	0.82	0.12
seminal vesicle, adult	10201-103F3	51.85	15.87	8.47	1.59	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	62.67	8.99	5.59	1.70	0.73	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	24.91	3.27	1.01	0.25	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	45.16	7.02	1.00	3.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	20.15	3.63	4.43	0.40	0.40	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	27.63	4.86	2.76	0.22	0.66	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	24.51	3.35	1.42	0.26	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	7.09	0.00	4.26	9.22	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	10.79	2.40	11.87	2.52	2.52	0.24
skeletal muscle, fetal, donor1	10066-101I3	12.06	4.02	6.03	3.02	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	22.72	10.73	9.47	0.63	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	56.70	17.01	3.34	1.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	47.91	10.40	9.46	1.26	1.26	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	7.13	4.63	19.47	2.31	3.08	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	42.69	7.09	2.31	0.82	0.49	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	10.13	1.77	6.27	3.22	0.80	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	90.65	22.45	3.49	0.44	0.44	0.00
small intestine, adult, pool1	10024-101D6	52.91	12.54	11.11	4.90	3.22	0.48
small intestine, fetal, donor1	10064-101I1	31.69	9.58	9.34	1.47	1.47	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	52.32	9.23	4.62	2.05	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	35.41	15.25	13.70	0.52	2.33	0.52
somatostatinoma cell line:QGP-1	10781-110G7	43.69	5.90	1.61	0.00	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	33.72	8.95	19.96	3.67	5.28	1.15
spinal cord, adult, donor10252	10159-103A6	55.20	20.90	31.15	5.52	5.52	0.00
spinal cord, adult, donor10258	10369-105F9	67.80	11.76	26.29	2.08	11.76	2.08
spinal cord, fetal, donor1	10056-101H2	48.18	15.86	17.08	1.83	4.88	0.61
spinal cord, newborn, donor10223	10359-105E8	48.22	10.56	17.45	1.84	9.64	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	35.40	5.82	2.54	1.19	0.30	0.00
spleen, adult, pool1	10025-101D7	21.92	4.30	3.19	7.82	1.76	0.44
spleen, fetal, pool1	10044-101F8	17.80	4.13	3.18	7.15	1.59	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	2.90	1.45	2.79	4.35	1.86	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	9.68	2.66	1.14	0.19	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	14.68	6.64	3.84	1.40	2.45	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	47.69	9.77	1.56	1.17	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	48.63	7.32	3.04	0.45	0.56	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	44.90	7.20	0.85	1.69	1.69	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	86.73	13.12	3.38	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	30.97	7.48	10.68	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	21.65	1.71	6.84	2.28	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	54.27	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	55.46	23.89	26.38	3.12	10.18	1.04
substantia nigra, adult, donor10258	10371-105G2	65.17	9.83	10.35	3.62	5.17	1.03
substantia nigra, newborn, donor10223	10358-105E7	42.39	4.95	7.07	4.24	3.53	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	20.40	6.88	4.13	0.23	0.92	0.23
temporal lobe, adult, pool1	10031-101E4	23.74	7.21	14.07	1.53	7.04	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	54.13	9.97	28.49	0.00	3.56	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	51.87	9.23	21.54	0.44	3.08	0.44
tenocyte, donor1	11763-123H8	35.61	5.59	3.49	0.35	0.35	0.00
tenocyte, donor2	11765-123I1	48.83	8.39	4.20	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	50.41	9.64	2.59	1.11	1.11	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	67.81	13.09	2.89	2.21	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	17.26	2.00	2.00	0.00	0.31	0.00
teratocarcinoma cell line:PA-1	10807-111A6	44.17	4.80	2.32	0.46	0.62	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.45	5.33	0.38	1.02	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	35.17	3.40	0.76	1.13	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	19.09	4.14	1.53	0.65	0.33	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	27.68	5.54	1.63	1.95	0.33	0.00
testis, adult, pool1	10026-101D8	31.67	9.02	17.18	6.55	7.19	0.75
testis, adult, pool2	10096-102C6	18.04	5.86	19.85	8.57	7.67	0.00
thalamus - adult, donor10196	10168-103B6	75.07	12.14	22.08	2.21	13.25	0.00
thalamus, adult, donor10252	10154-103A1	60.48	28.60	25.47	3.91	10.63	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	147.80	4.62	6.16	6.16	3.08	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	32.11	4.78	8.56	2.31	3.29	0.16
thalamus, newborn, donor10223	10366-105F6	26.46	4.60	14.38	5.18	6.90	0.58
throat, adult	10209-103G2	19.22	5.24	10.99	3.00	3.00	0.00
throat, fetal, donor1	10061-101H7	38.09	9.14	16.15	3.05	2.13	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	57.43	8.94	11.92	0.60	1.59	0.20
thymus, adult, pool1	10027-101D9	9.54	2.98	10.84	57.16	7.75	1.49
thymus, fetal, pool1	10043-101F7	14.75	3.53	9.97	46.65	7.69	2.70
thyroid carcinoma cell line:KHM-5M	10776-110G2	52.79	3.59	0.40	0.27	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	7.96	6.01	58.11	17.18	5.73	1.68
thyroid, adult, pool1	10028-101E1	63.73	17.73	29.67	0.93	2.89	0.09
thyroid, fetal, donor1	10060-101H6	40.34	17.14	14.50	1.05	1.32	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	9.24	9.24	0.00	3.08	0.00
tongue, adult	10203-103F5	21.16	3.72	6.74	0.93	2.33	0.47
tongue, fetal, donor1	10059-101H5	27.98	8.28	9.06	2.76	2.36	0.39
tonsil, adult, pool1	10047-101G2	14.02	2.91	4.41	11.82	2.80	0.40
trachea, adult, pool1	10029-101E2	28.96	6.79	4.34	1.72	1.47	0.08
trachea, fetal, donor1	10058-101H4	20.00	4.62	6.92	1.92	0.38	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	20.55	5.67	1.77	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	41.84	4.56	0.91	0.20	0.20	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	21.62	5.48	3.92	0.78	0.63	0.16
tridermal teratoma cell line:HGRT	10694-109G1	49.47	3.81	5.71	3.81	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	15.07	4.99	3.39	0.34	0.42	0.08
umbilical cord, fetal, donor1	10057-101H3	45.90	12.52	2.09	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	35.49	8.36	7.85	0.51	2.05	0.17
uterus, fetal, donor1	10055-101H1	31.23	8.19	9.21	1.02	1.54	0.00
vagina, adult	10204-103F6	38.13	6.46	9.69	0.65	1.29	0.00
vein, adult	10191-103E2	18.19	2.41	6.36	8.55	1.32	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.14	2.40	3.74	2.40	0.80	0.53